12:00 AM
 | 
Feb 07, 2000
 |  BC Week In Review  |  Company News  |  Deals

InSite, Okayama University deal

ISV received an exclusive worldwide license to the university's oculomedin gene, which the...

Read the full 41 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >